In-Vitro Lung Model Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the In-Vitro Lung Model Market Size By 2025?
Recently, the size of the in-vitro lung model market has seen rapid expansion. Its forecasted growth predicts an increase from $0.44 billion in 2024, to $0.54 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 21.0%. Several factors contribute to the growth experienced in this historical period, such as the rising incidence of respiratory illnesses, heightened interest in personal medicine, a surge in attention towards drug repositioning, a focus on precision medicine pathways and increased consciousness regarding environmental health hazards.

How Big Is the In-Vitro Lung Model Market Size Expected to Grow by 2029?
There is expected to be a substantial increase in the size of the in-vitro lung model market in the upcoming years, with projections showing it reaching $1.11 billion in 2029, advancing at a compound annual growth rate (CAGR) of 19.8%. This expansion during the predicted period can be linked to several factors including, but not limited to, the necessity for drug development, escalation of preclinical trials, the growing prominence of respiratory toxicology, a focus shift towards regenerative medication, emerging environmental issues, and the rising elderly population. Key trends predicted to influence this market in future years consist of a surging demand for drug testing, advancements in technology such as 3D printing and organ-on-chip, the integration of Artificial Intelligence and machine learning, the inclusion of sensors and monitoring devices, diversifying applications beyond the pharmaceutical industry, and the creation of disease-specific models.

View the full report here:
https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Key Market Drivers Powering In-Vitro Lung Model Market Expansion and Growth?
The anticipated rise in clinical investigations is set to drive the expansion of the in vitro lung model market. Clinical investigations, which gauge the effectiveness of new medical methodologies in humans, are witnessing a surge due to the escalating need for cutting-edge medical treatments, heightened healthcare demands, and the quest for inventive solutions for intricate health problems. In vitro lung models contribute to clinical trials by offering a regulated setting to analyze the influence of substances on lung tissue, facilitating drug testing, toxicity evaluation, disease modeling, and comprehending disease mechanisms. For example, as reported by ClinicalTrials.gov, a US clinical trial registry, there were 477,230 clinical trials registered worldwide by the end of 2023, marking an increase from the 437,508 clinical trials registered in 2022. Thus, the surge in clinical studies is driving the growth of the in vitro lung model market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

What Trends Will Shape the In-Vitro Lung Model Market Through 2029 and Beyond?
Leading businesses in the invitro lung model industry are innovating 3D respiratory tissue models to improve the physiological relevance and complexity of their models. These 3D tissue models are generated by growing chosen respiratory cells in a niche environment, which permits them to form a three-dimensional structure that simulates the function and structure of the respiratory system. This setup offers a valuable platform for research and drug trials. For example, MatTek Corporation, a biotech firm based in the US, launched EpiNasal, a groundbreaking 3D respiratory tissue model composed of primary human nasal epithelial cells, in April 2023. It successfully imitates the tri-dimensional structure and functionality of the nasal epithelium, comprising mucus-secreting goblet cells, operational tight junctions, and constantly beating cilia. The addition of EpiNasal to MatTek's line of 3D respiratory tissue models widens its collection. This model provides an all-inclusive system for studying the impact of pharmaceuticals, chemicals, pathogens, and consumer goods on the human respiratory system.

What Are the Emerging Segments in the In-Vitro Lung Model Market?
The in-vitro lung model market covered in this report is segmented -

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model
2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications
3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:
1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures
2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

Who Are the Global Leaders in the In-Vitro Lung Model Market?
Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Dra*per Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

Which are the Top Profitable Regional Markets for the In-Vitro Lung Model Industry?
North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15837

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.